These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1118 related articles for article (PubMed ID: 4422190)

  • 1. A lymphocytotoxicity assay not requiring the in vitro culture of target tumor cells.
    Kreider JW; Flickinger JT; Lengle N; Shoff W
    Transplantation; 1974 Sep; 18(3):223-8. PubMed ID: 4422190
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro tumor cell destruction by syngeneic mouse macrophoages: methods for assaying cytotoxicity.
    Norbury KC; Fidler IJ
    J Immunol Methods; 1975 Apr; 7(1):109-22. PubMed ID: 1123549
    [No Abstract]   [Full Text] [Related]  

  • 3. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells.
    Ting C-C ; Bushar GS; Rodrigues D; Herberman RB
    J Immunol; 1975 Nov; 115(5):1351-6. PubMed ID: 170343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuraminidase-induced enhancement of tumor growth in mice.
    Froese G; Berczi I; Sehon AH
    J Natl Cancer Inst; 1974 Jun; 52(6):1905-8. PubMed ID: 4834417
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro studies on cell-mediated cytotoxicity by means of a terminal labeling technique.
    More R; Yron I; Sasson SB; Weiss DW
    Cell Immunol; 1975 Feb; 15(2):382-91. PubMed ID: 122915
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro studies of cellular-mediated immunostimulation of tumor growth.
    Fidler IJ
    J Natl Cancer Inst; 1973 May; 50(5):1307-12. PubMed ID: 4712593
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC; Nunn ME; Park JY; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. I. Basic parameters: baseline controls, target cells, and methods of calculation.
    Ting CC; Park JY; Nunn ME; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):323-30. PubMed ID: 833880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytotoxic immunity indices of melanoma B16 growth in mice].
    Korosteleva TA; Veresova OV
    Vopr Onkol; 1980; 26(1):67-70. PubMed ID: 7355591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A diffusion chamber method for the detection of lymphocyte-mediated cytotoxicity of 125 IUdR-labeled tumor cells.
    Kreider JW; Shoff WH; Lengle N
    Transplantation; 1972 Aug; 14(2):278-83. PubMed ID: 5049336
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunostimulation-inhibition of tumor cell growth in vitro utilizing tumor target cells labeled with 125I-iodo-deoxyuridine.
    Fidler IJ
    Immunol Commun; 1973; 2(5):483-93. PubMed ID: 4757433
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased immunogenicity of B16 melanoma clones selected for their ability to metastasize from a heterogeneous primary tumor.
    Steele GD; Richie JP; Wang BS; Mannick JA; Wilson RE
    Surg Forum; 1979; 30():132-3. PubMed ID: 538574
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells.
    Oldham RK; Herberman RB
    J Immunol; 1973 Dec; 111(6):862-71. PubMed ID: 4750872
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.
    Burton R; Thompson J; Warner NL
    J Immunol Methods; 1975; 8(1-2):133-49. PubMed ID: 807654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 17. Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants.
    Fidler IJ
    J Natl Cancer Inst; 1975 Nov; 55(5):1159-63. PubMed ID: 1206741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The augmentation of concomitant tumor immunity with RNA.
    Wang BS; Deckers PJ
    J Surg Res; 1976 Mar; 20(3):183-94. PubMed ID: 1263482
    [No Abstract]   [Full Text] [Related]  

  • 19. A new micromethod for the detection of HL-A antigens on cultured human tumor cells.
    Fritze D; Kern DH; Drogemuller CR; Pilch YH
    Transplantation; 1975 Sep; 20(3):211-8. PubMed ID: 125940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
    Le Mevel BP; Oldham RK; Wells SA; Herberman RB
    J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 56.